CN1279893C - 表面活性剂化合物及其用途 - Google Patents

表面活性剂化合物及其用途 Download PDF

Info

Publication number
CN1279893C
CN1279893C CNB028193539A CN02819353A CN1279893C CN 1279893 C CN1279893 C CN 1279893C CN B028193539 A CNB028193539 A CN B028193539A CN 02819353 A CN02819353 A CN 02819353A CN 1279893 C CN1279893 C CN 1279893C
Authority
CN
China
Prior art keywords
formula
alkylene
compound
compounds
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028193539A
Other languages
English (en)
Chinese (zh)
Other versions
CN1561198A (zh
Inventor
I·卡尔多尔
B·E·罗克
C·J·伦尼斯
A·J·雷德格拉夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0118994A external-priority patent/GB0118994D0/en
Priority claimed from GB0206892A external-priority patent/GB0206892D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CN1561198A publication Critical patent/CN1561198A/zh
Application granted granted Critical
Publication of CN1279893C publication Critical patent/CN1279893C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C07C59/135—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/63—Halogen-containing esters of saturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Materials Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CNB028193539A 2001-08-03 2002-08-02 表面活性剂化合物及其用途 Expired - Fee Related CN1279893C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0118994A GB0118994D0 (en) 2001-08-03 2001-08-03 Compounds
GB0118994.3 2001-08-03
GB0206892.2 2002-03-23
GB0206892A GB0206892D0 (en) 2002-03-23 2002-03-23 Compounds

Publications (2)

Publication Number Publication Date
CN1561198A CN1561198A (zh) 2005-01-05
CN1279893C true CN1279893C (zh) 2006-10-18

Family

ID=26246403

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028193539A Expired - Fee Related CN1279893C (zh) 2001-08-03 2002-08-02 表面活性剂化合物及其用途

Country Status (20)

Country Link
US (1) US7195752B2 (https=)
EP (2) EP1411896B1 (https=)
JP (2) JP2005501082A (https=)
KR (1) KR20040025738A (https=)
CN (1) CN1279893C (https=)
AT (2) ATE373469T1 (https=)
AU (1) AU2002321422B2 (https=)
BR (1) BR0211656A (https=)
CA (1) CA2456052A1 (https=)
CO (1) CO5550416A2 (https=)
DE (2) DE60210102T2 (https=)
ES (2) ES2293157T3 (https=)
HU (1) HUP0401194A2 (https=)
IL (1) IL160114A0 (https=)
MX (1) MXPA04001049A (https=)
NO (1) NO20040462L (https=)
NZ (1) NZ530828A (https=)
PL (1) PL368805A1 (https=)
RU (1) RU2004103075A (https=)
WO (1) WO2003013610A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125127D0 (en) * 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
KR20040086370A (ko) 2002-02-13 2004-10-08 글락소 그룹 리미티드 계면활성제로서 사용되는 카르복실산 화합물
GB0323701D0 (en) * 2003-10-09 2003-11-12 Glaxo Group Ltd Formulations
WO2005099718A1 (en) * 2004-04-19 2005-10-27 Centre National De La Recherche Scientifique (C.N.R.S.) Lung surfactant supplements
CA2575297C (en) 2004-08-04 2014-09-23 Acea Biosciences, Inc. Method for assaying for natural killer, cytotoxic t-lymphocyte and neutrophil-mediated killing of target cells using real-time microelectronic cell sensing technology
DE102005000858A1 (de) * 2005-01-05 2006-07-20 Merck Patent Gmbh Fluortenside
PL240578B1 (pl) * 2018-10-26 2022-05-02 Nanosanguis Związek chemiczny będący solą amoniową częściowo fluorowanych kwasów organicznych oraz jego zastosowania

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250808A (en) * 1963-10-31 1966-05-10 Du Pont Fluorocarbon ethers derived from hexafluoropropylene epoxide
US3498923A (en) * 1966-10-18 1970-03-03 Us Navy Surface-active compositions and method for displacing liquid organic films from solid surfaces
JPS5331582A (en) 1976-09-04 1978-03-24 Daikin Ind Ltd Aerosol composition
US4346235A (en) * 1979-06-15 1982-08-24 Okamura Oil Mill Limited Fluorine-containing compounds
JPS62297478A (ja) 1986-06-18 1987-12-24 Nippon Soda Co Ltd 表面処理剤およびその製造方法
FR2613357B1 (fr) * 1987-04-06 1989-06-16 Atochem Trifluoromethylation de composes organiques insatures
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
AU654813B2 (en) * 1990-03-23 1994-11-24 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
NZ238749A (en) 1990-06-28 1993-07-27 Glaxo Inc Aerosol inhalation drug formulations with 1,1,1,2-tetrafluoroethane as propellant and a perfluorinated surfactant
JPH04283538A (ja) 1991-03-13 1992-10-08 Neos Co Ltd 含フッ素カルボン酸誘導体
JP2668760B2 (ja) 1992-06-02 1997-10-27 スカイアルミニウム 株式会社 アルカリ化学粗面化用アルミニウム合金展伸材およびその製造方法
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19608278A1 (de) * 1996-02-23 1997-08-28 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
DE19731300C1 (de) 1997-07-11 1999-01-21 Schering Ag Perfluoralkylgruppenhaltige Trijodaromaten, Verfahren zu deren Herstellung und deren Verwendung als Kontrastmittel
DE19731591C2 (de) 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers

Also Published As

Publication number Publication date
EP1411896A2 (en) 2004-04-28
DE60222591T2 (de) 2008-06-19
HUP0401194A2 (hu) 2004-11-29
JP2006008695A (ja) 2006-01-12
MXPA04001049A (es) 2004-05-20
WO2003013610A2 (en) 2003-02-20
JP2005501082A (ja) 2005-01-13
US20040234556A1 (en) 2004-11-25
EP1411896B1 (en) 2006-03-22
CA2456052A1 (en) 2003-02-20
ATE320795T1 (de) 2006-04-15
US7195752B2 (en) 2007-03-27
IL160114A0 (en) 2004-06-20
KR20040025738A (ko) 2004-03-25
CO5550416A2 (es) 2005-08-31
DE60222591D1 (de) 2007-10-31
DE60210102D1 (de) 2006-05-11
DE60210102T2 (de) 2006-08-31
BR0211656A (pt) 2004-07-13
ES2293157T3 (es) 2008-03-16
CN1561198A (zh) 2005-01-05
RU2004103075A (ru) 2005-04-20
AU2002321422B2 (en) 2006-05-25
EP1486203A2 (en) 2004-12-15
PL368805A1 (en) 2005-04-04
EP1486203B1 (en) 2007-09-19
NZ530828A (en) 2005-10-28
WO2003013610A3 (en) 2003-10-30
ATE373469T1 (de) 2007-10-15
ES2260468T3 (es) 2006-11-01
EP1486203A3 (en) 2005-03-16
NO20040462L (no) 2004-03-23

Similar Documents

Publication Publication Date Title
CN1200690C (zh) 加压计量吸入器(mdi)
CN1067578A (zh) 非含氯氟烃的气雾剂配方
CN1067579A (zh) 非含氯氟烃的气雾剂配方
CN1291986C (zh) 抗胆碱能剂,其制备方法及其作为药物的用途
CN1110473C (zh) 从制品上除去污染物的方法
CN1713914A (zh) 用于治疗慢性阻塞性肺病的新药物
CN1243723C (zh) 作为fsad的nep抑制剂的n－苯丙基环戊基取代的戊二酰胺衍生物
CN1950323A (zh) Crth2受体拮抗剂
CN1324025C (zh) 作为ccr5调节剂的托烷衍生物
CN1279893C (zh) 表面活性剂化合物及其用途
CN1240658C (zh) 含氟酮的制造方法
CN1239940A (zh) α－支化的氟烷基酰氟及其衍生物
CN1239897A (zh) 水性的成膜泡沫组合物
CN1246281C (zh) 含氟化合物的制造方法
CN1856465A (zh) 氨基取代的乙氨基β2－肾上腺素能受体激动剂
JP2004509159A (ja) 新規なアルカン酸誘導体
CN1239483A (zh) 水性含氟聚合物组合物及其制备方法
CN1140527C (zh) 苯基黄嘌呤酯和酰胺衍生物
CN1133621C (zh) 环己二醇衍生物
JP2005525300A (ja) 界面活性剤として使用するための化合物
AU2002321422A1 (en) Surfactant compounds and uses thereof
CN1675179A (zh) 用作光致抗蚀剂的具有稠合的4－元杂环的多环基团的氟化单体,氟化聚合物和用于微石印术的方法
CN101056640A (zh) 用于吸入β－拮抗剂的气溶胶制剂
CN1747923A (zh) 全氟二酰氟化合物的制备方法
CN1431985A (zh) 由热分解反应制造不饱和化合物的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee